Tesla has given back ground this week, and the most revealing detail is that neither shorts nor options traders have changed their minds much.
The stock closed at $423.74 on Tuesday, down 2.3% on the week after touching $435.79 last Thursday. That puts it roughly 3% above the analyst mean price target of $412 — the gap that opened in late May has narrowed but not closed. A month ago the stock was below consensus; now it is trading ahead of it, a reversal that still makes this valuation conversation different from earlier in the year. The one-month gain remains 8.4%, so the weekly pullback reads more like consolidation than a trend break.
Options traders are leaning bullish by recent standards, and that is a genuine shift from last week. The put/call ratio is running at 0.73, roughly 1.5 standard deviations below its 20-day average of 0.75 — meaning call buying has outpaced puts noticeably. That is close to the most bullish options positioning Tesla has seen over the past year, with the 52-week low in PCR sitting at 0.68. The borrow market tells a different story. Short interest dipped slightly on the week to 2.27% of free float — about 75.6 million shares — but that is barely changed from the ~2.3% level documented in last week's note. More pointed: it remains well above the ~71 million share count from late April, meaning the buildup from that period has not unwound. Borrow cost ticked up to 0.43%, a 13% rise on the week, though in absolute terms it stays low. Availability is extremely loose — there is no squeeze pressure here.
The Street picture is nuanced. Analyst activity has been quiet in recent weeks; the last cluster of meaningful moves came on April 23, when targets were shuffled post-earnings across the board. The bulls — Wedbush at $600, Cantor Fitzgerald at $510, TD Cowen at $490, RBC at $475 — all hold positive ratings with targets well above the current price. The neutrals, led by UBS at $364 and Needham on Hold, anchor a mean target of $412. With the stock now at $423, it has traded through the mean, which is unusual for Tesla. Valuation remains stretched: the P/E is running near 189 and EV/EBITDA above 91. The ORTEX short score is stable at 30.6, having barely moved over the past two weeks. Days-to-cover ranks in the 89th percentile, a function of the stock's liquidity rather than any particular short squeeze dynamic.
Insider activity adds a mildly cautious footnote. CFO Vaibhav Taneja sold $1.35 million of stock on May 13 at $450 — above the current price — and independent director Kathleen Wilson-Thompson executed a series of sales totalling roughly $6.4 million on April 30. Net 90-day insider activity is marginally positive in share terms, but the recent directional selling from named officers at prices above where the stock trades now is worth noting. Among peers, RIVN added 20% on the week while XPEV rose 8% — both outpacing Tesla meaningfully. LCID fell 7% on Tuesday alone, a reminder of how bifurcated EV sentiment remains.
The next scheduled catalyst is the Q2 earnings report on July 22. After the most recent print in April the stock fell 3.3% in a day and 3.5% over the following week, continuing a pattern where Tesla's results have not reliably driven upside moves. Between now and then, the conversation to watch is whether the SpaceX merger speculation — which drove much of the May narrative — either gets substantive confirmation or quietly fades, and whether the stock can hold its premium to analyst consensus with no new upgrades arriving to justify it.
See the live data behind this article on ORTEX.
Open TSLA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
